Bridgeway Capital Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $264,225 - $527,095	-135,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $931,895 - $1.51 Million	-244,592 Reduced 64.35%	135,500 $534,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $67,600 - $107,000	-20,000 Reduced 5.0%	380,092 $1.83 Million
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $306,940 - $437,315	-74,500 Reduced 15.7%	400,092 $1.84 Million
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $1.22 Million - $3.21 Million	-353,600 Reduced 42.7%	474,592 $2.79 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $451,290 - $1.58 Million	429,800 Added 107.88%	828,192 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $183,386 - $241,021	104,792 Added 35.69%	398,392 $795,000
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $528,480 - $1.26 Million	293,600 New	293,600 $573,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.